Gallbladder Adenocarcinoma — Clinical Trials

MONDO:00062154 active·3 recruitingLast updated: Mar 20, 2026, 3:16 PM

Trial Landscape

Gallbladder Adenocarcinoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment3

Procedure1

Biological Therapy1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Sponsor Types

Academic/Other4

Trial Locations

United States4 trials

Trials often recruit across multiple countries, so totals exceed the trial count.

4 Trials

Phase 3Recruiting

NCT05482516

Evaluating Novel Therapies in ctDNA Positive GI Cancers

Sponsor:Georgetown University

United StatesStarted: Mar 2023Est. completion: Dec 2028Updated: May 2025

Phase 2Recruiting

NCT07282912

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Sponsor:Yale University

United StatesStarted: Mar 2026Est. completion: Jun 2028Updated: Mar 2026

Early Phase 1Recruiting

NCT05430035

Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

Sponsor:West Virginia University

United StatesStarted: Jun 2022Est. completion: Jul 2029Updated: Feb 2025

Phase 1Active, Not Recruiting

NCT03257761

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Sponsor:University of Southern California

United StatesStarted: Feb 2018Est. completion: Jul 2026Updated: Dec 2025

Stay informed about clinical trials for Gallbladder Adenocarcinoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 3:16 PM